-
Your selected country is
Spain
- Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
BD™ Multi-Check CD4 Low Control Whole Blood Control for Lymphocyte Subset Enumeration
(CE_IVD)
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Description
The BD™ Multi-Check CD4 low control is intended as a complete process control for immunophenotyping by flow cytometry. It is a control for antibody staining, red blood cell (RBC) lysis, instrument setup and performance, and data analysis.
Preparation And Storage
• Store vials upright, tightly capped, at 2° to 8°C when not in use.
• Unopened vials are stable until the expiration date indicated on each vial and Assay Values sheet.
• Opened vials are stable for 9 thermal cycles (uses) when handled properly. A thermal cycle constitutes performing all steps under Instructions for Use once.
• Avoid unnecessary cycles of warming and cooling.
• Protect from freezing, from temperatures above 30°C, and from prolonged time (>30 minutes) at room temperature (18° to 26°C).
• Follow exactly the steps under Instructions for Use.
Development References (2)
-
Centers for Disease Control. Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR. 1997; 46:1-29. (Biology).
-
Clinical Applications of Flow Cytometry: Quality Assurance and Immunophenotyping of Lymphocytes: Approved Guideline. NCCLS document H42-A. 1998. (Biology).
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For In Vitro Diagnostic Use.
23-22942-00
Documents are subject to revision without notice. Please verify you have the correct revision of the document, and always refer back to BD's eIFU website for the latest and most up to date information.